Improving diagnostic tests for Hepatitis B
Official title: RADx Innovation Funnel for Hepatitis B Diagnostics - Coordination Center
Funded at Massachusetts General Hospital · NIH-11205649 · Data updated 2026-11-12
This study is working on creating faster and more reliable tests for Hepatitis B, so patients can get easier access to testing and start treatment sooner.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | September 30, 2024 |
| Project end | September 29, 2026 |
| Funding year | 2024 |
| Award (this year) | $190,000 |
| NIH project number | 75N92022D00014-0-759202400003-1 |
| Project ID | NIH-11205649 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at risk for Hepatitis B or those experiencing symptoms related to the infection.
✕Less likely to help
Patients who have already been diagnosed and are receiving effective treatment for Hepatitis B may not benefit directly from this research.
What this research studies
This research focuses on developing and accelerating the availability of accurate and reliable diagnostic tests for Hepatitis B. By utilizing innovative point-of-care technologies, the project aims to enhance the speed and efficiency of diagnosing this viral infection. Patients may benefit from more accessible testing options that can lead to timely treatment and management of Hepatitis B. The research involves collaboration with various stakeholders to ensure that the diagnostic tools meet regulatory standards and patient needs.
Why it matters
Potential benefit: If successful, this research could provide patients with faster and more reliable diagnostic tests for Hepatitis B, leading to improved health outcomes.
How similar studies have gone: Previous research in the RADx program has shown success in accelerating the development of diagnostic technologies for various conditions, indicating a promising approach for Hepatitis B diagnostics.
Where this research is happening
-
Massachusetts General Hospital
Boston, United States Active
Researchers
- Principal investigator: Schachter, Steven C. — Massachusetts General Hospital
- Study coordinator: Schachter, Steven C.
Related research
Other NIH-funded projects on the same topics.
-
HBV cure clues in people with and without HIV
This project studies how HBV-specific B and T cell responses relate to curing hepatitis B in people with and without HIV.
-
HBV cure factors in people with and without HIV
This project studies how HBV-specific immune cells behave during treatment and whether people with HIV respond differently than those without HIV.
-
HBV prevention in community pharmacies: a first step in a low-resource setting
This pilot project tests whether hepatitis B screening and vaccination can be integrated into everyday community pharmacy services to reach more people.
-
Blood markers to catch early liver cancer in Hispanic people with hepatitis B
This project will see if a blood test can find liver cancer earlier in Hispanic people who have chronic hepatitis B.
-
Early blood markers to find hepatitis B–related liver cancer in Hispanics
This project will use immune-related blood markers to find liver cancer earlier in people with chronic hepatitis B, focusing on Hispanic adults.
-
HBV safety with long-acting HIV therapy for people with HIV
A study to understand how long-acting HIV meds affect hepatitis B in people living with HIV and how to best monitor and protect them.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.